Dynamic and Static 18F-FDG PET/CT Imaging in SMARCA4-Deficient Non-Small Cell Lung Cancer and Response to Therapy: A Case Report
Open Access
- 13 June 2023
- journal article
- editorial
- Published by MDPI AG in Diagnostics
- Vol. 13 (12) , 2048
Abstract
SMARCA4-deficient non-small cell lung cancer (NSCLC) is a more recently recognized subset of NSCLC. We describe the 18F-fluorodeoxyglucose (FDG) PET/CT findings in a rare case of SMARCA4-deficient NSCLC and response to therapy. A 45-year-old male patient with a history of heavy smoking (10 years) underwent an 18F-fluorodeoxyglucose (FDG) PET/CT dynamic (chest) + static (whole-body) scan for diagnosis and pre-treatment staging. 18F-FDG PET/CT showed an FDG-avid mass in the upper lobe of the left lung (SUVmax of 22.4) and FDG-avid lymph nodes (LN) in the left pulmonary hilar region (SUVmax of 5.7). In addition, there were multiple metastases throughout the body, including in the distant LNs, adrenal glands, bone, left subcutaneous lumbar region, and brain. Pathological findings confirmed SMARCA4-deficient NSCLC. After four cycles of chemotherapy and immune checkpoint inhibitors (ICI), the patient underwent again an 18F-FDG PET/CT scan (including a dynamic scan) for efficacy evaluation. We report a case that deepens the understanding of the 18F-FDG PET/CT presentation of SMARCA4-deficient NSCLC as well as dynamic imaging features and parametric characteristics.Keywords
All Related Versions
Funding Information
- National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital (E010322003, SZ2020MS008)
- Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen (E010322003, SZ2020MS008)
- Shenzhen High–level Hospital Construction Fund (E010322003, SZ2020MS008)
This publication has 11 references indexed in Scilit:
- Dynamic FDG-PET imaging for differentiating metastatic from non-metastatic lymph nodes of lung cancerFrontiers in Oncology, 2022
- Smarca4 Inactivation Promotes Lineage-Specific Transformation and Early Metastatic Features in the LungCancer Discovery, 2021
- The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung CancerClinical Cancer Research, 2020
- SMARCA4/BRG1–Deficient Non–Small Cell Lung Carcinomas: A Case Series and Review of the LiteratureArchives of Pathology & Laboratory Medicine, 2020
- Non-small cell lung cancer with loss of expression of the SWI/SNF complex is associated with aggressive clinicopathological features, PD-L1-positive status, and high tumor mutation burdenLung Cancer, 2019
- Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case reportThoracic Cancer, 2019
- Dynamic whole-body PET imaging: principles, potentials and applicationsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2018
- SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg/CK7pos/HepPar-1pos immunophenotypeVirchows Archiv, 2017
- Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel SequencingCell, 2012
- Assessment of quantitative FDG PET data in primary colorectal tumours: which parameters are important with respect to tumour detection?European Journal of Nuclear Medicine and Molecular Imaging, 2007